 | Up a level |
Schandelmaier, S; Conen, K; von Elm, E; You, J J; Blümle, A; Tomonaga, Y; Saccilotto, R; Amstutz, A; Bengough, T; Meerpohl, J J; Stegert, M; Olu, K K; Tikkinen, K A O; Neumann, I; Carrasco-Labra, A; Faulhaber, M; Mulla, S M; Mertz, D; Akl, E A; Sun, X; ... (2015). Planning and reporting of quality-of-life outcomes in cancer trials. Annals of oncology, 26(9), pp. 1966-1973. Oxford University Press 10.1093/annonc/mdv283
Briel, M; Bucher, H C; Boscacci, R; Furrer, H (2006). Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. Cochrane database of systematic reviews, 3(3), CD006150. Chichester: WileyInterscience 10.1002/14651858.CD006150
Briel, M; Boscacci, R; Furrer, H; Bucher, HC (2005). Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials. BMC infectious diseases, 5(5), p. 101. London: BioMed Central 10.1186/1471-2334-5-101
